Business Context and Reporting Period
This Form 8-K Current Report from PubMatic, Inc. (PUBM) covers events occurring on December 25, 2021, with the report filed on December 27, 2021. The filing addresses the passing of a Board member and the resulting impact on the company's compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Board Composition: Narendra Gupta, a member of the Board of Directors, Audit Committee, and Nominating and Corporate Governance Committee, passed away on December 25, 2021.
- Listing Compliance: Due to Mr. Gupta's death, the Audit Committee no longer meets the minimum requirement of three independent directors under Nasdaq Listing Rule 5605(c)(2)(A).
- Regulatory Status: Nasdaq confirmed the noncompliance on December 29, 2021, and granted the company a cure period.
Outlook, Risks, and Management Commentary
Management expressed deep regret over the loss of Mr. Gupta and extended condolences to his family. The company intends to appoint an additional independent director to the Audit Committee to regain compliance before the cure period expires. The cure period ends on the earlier of the 2022 Annual Meeting of stockholders or December 25, 2022 (or June 23, 2022, if the Annual Meeting is held before that date). The primary risk identified is the potential delisting or failure to satisfy continued listing rules if compliance is not restored within the specified timeframe.
Investor Verification Checklist
- Verify the appointment of a new independent director to the Audit Committee.
- Monitor the date of the 2022 Annual Meeting to determine the exact deadline for regaining compliance.
- Confirm that the Audit Committee composition meets the three-independent-director requirement prior to the cure period expiration.